Perry’s The Chemotherapy Source Book, 5th Edition

Perry’s The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs.  Organized by site, this is the only book of its kind to focus strictly on the clinical practice of chemotherapy, and is meant to serve as a “one-stop shop” for information on choice of chemotherapeutic agents, treatment outlines, grading of side effects, and dose modification.

Table of Contents

Section I Scientific Principles of Chemotherapy
Chapter 1. Scientific Basis of Cancer Chemotherapy
Chapter 2. Norton–Simon Hypothesis
Chapter 3. Drug Resistance
Chapter 4. Principles of Chemotherapy
Chapter 5. Clinical Trials
Chapter 6. Hematopoietic Growth Factors
Chapter 7. Biologic Response Modifiers: Principles of Biotherapy

Section II Routes of Administration
Chapter 8. Intraventricular and Intrathecal Therapy
Chapter 9. Intraperitoneal Chemotherapy
Chapter 10. Intraarterial Chemotherapy
Chapter 11. Hematopoietic Stem Cell Transplantation

Section III Management of Drug Toxicity
Chapter 12. Oral Toxicity
Chapter 13. Dermatologic Toxicity
Chapter 14. Extravasation
Chapter 15. Hypersensitivity Reactions
Chapter 16. Ocular Side Effects of Cancer Therapeutics
Chapter 17. Cardiotoxicity of Cancer Therapy
Chapter 18. Pulmonary Toxicity of Chemotherapeutic Agents
Chapter 19. Gastrointestinal Complications of Chemotherapy
Chapter 20. Hepatotoxicity of Chemotherapeutic Agents
Chapter 21. Chemotherapy-Induced Renal and Electrolyte Dysfunction
Chapter 22. Chemotherapy-Induced Peripheral Neuropathy
Chapter 23. Vascular Toxicity of Antineoplastic Agents
Chapter 24. Second Malignancies after Chemotherapy
Chapter 25. Chemotherapy in Pregnancy
Chapter 26. Gonadal Complications and Teratogenicity of Cancer Therapy

Section IV Drug Administration
Chapter 27. Central Venous Access for Chemotherapy

Section V Current Therapy of Specific Solid Tumors
Chapter 28. Systemic Therapy for Advanced Melanoma
Chapter 29. Chemotherapy of Primary Brain Tumors
Chapter 30. Chemotherapy Head and Neck Cancer
Chapter 31. Chemotherapy of Lung Cancer
Chapter 32. Breast Cancer
Chapter 33. Gastrointestinal Cancer
Chapter 34. Endocrine Tumors
Chapter 35. Chemotherapy of Genitourinary Cancer
Chapter 36. Chemotherapy of Gynecologic Cancers
Chapter 37. Chemotherapy of Carcinoma of Unknown Primary Site
Chapter 38. Chemotherapy of Bone and Soft Tissue Sarcomas
Chapter 39. Chemotherapy for Pediatric Solid Tumors

Section VI Chemotherapy of Hematologic Malignancies
Chapter 40. Chemotherapy for Childhood Leukemia
Chapter 41. Chemotherapy of Hodgkin Lymphoma
Chapter 42. Non-Hodgkin Lymphoma
Chapter 43. Chronic Lymphocytic Leukemia
Chapter 44. Acute Myeloid Leukemia
Chapter 45. Myelodysplastic Syndromes
Chapter 46. Management of Myeloproliferative Disorders and Chronic Myeloid Leukemia
Chapter 47. Chemotherapy of Multiple Myeloma

Section VII Appendices
Appendix I Chemotherapeutic Agents
Appendix II CHEMOTHERAPY PROGRAMS
Appendix III Common Terminology Criteria for Adverse Events v4.0 (CTCAE)